UK markets closed

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
128.77-8.73 (-6.35%)
As of 02:55PM EST. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,104,982
933,013
701,887
540,099
Cost of revenue
136,966
139,989
97,049
63,382
Gross profit
968,016
793,024
604,838
476,717
Operating expenses
Research development
895,674
877,090
771,182
722,343
Selling general and administrative
470,649
451,421
282,660
317,875
Total operating expenses
1,367,298
1,329,225
1,054,548
1,040,880
Operating income or loss
-399,282
-536,201
-449,710
-564,163
Interest expense
23,464
53,248
63,525
59,947
Total other income/expenses net
-306,688
-117,002
93,933
68,075
Income before tax
-661,775
-689,963
-418,948
-553,065
Income tax expense
29,101
13,525
-168
1,063
Income from continuing operations
-690,876
-703,488
-418,780
-554,128
Net income
-690,876
-703,488
-418,780
-554,128
Net income available to common shareholders
-690,876
-703,488
-418,780
-554,128
Basic EPS
-7.80
-8.03
-5.15
-7.11
Diluted EPS
-7.80
-8.03
-5.15
-7.11
Basic average shares
88,417
87,559
81,262
77,956
Diluted average shares
88,417
87,559
81,262
77,956